CBT

Rank #296

Rank #296 by gross profitability (GP/assets 0.24) · ROE 21.1% · Piotroski F-Score 6 / 9.

As-of 2026-07-22 · CIK 0000016040 · all metrics point-in-time as of the filing date.

Profitability

Gross profitability (GP / assets)

0.24

Primary signal (Novy-Marx).

Return on equity

21.1%

Gross margin

25.3%

Revenue growth (YoY)

-7.0%

Gross margin improving

Margin trend vs prior year.

PASS

Anti-fragile safety

Balance-sheet safety

Composite anti-fragile check.

PASS

Debt / equity

1.31

Current ratio

1.45×

Quick ratio

—

Net cash

-$1.05B

Cash & equivalents minus total debt.

Cash-flow health

Free cash flow

$391.00M

Operating cash flow minus capex.

Positive free cash flow

PASS

FCF / net income

0.18

Cash-backing of earnings.

FCF/NI divergence

Unfavorable divergence (yellow flag).

PASS

Accruals healthy

Cash-backed earnings.

PASS

SBC / revenue

0.6%

Stock-based comp intensity.

Piotroski F-Score

F-Score

6 / 9

Fundamental-strength score (0-9).

View full financial statements →